PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What are biologic treatments for moderate to severe psoriasis?

ANSWER

Biologic drugs target the immune response that causes inflammation.

SOURCES:

American Academy of Dermatology. Bhosle, M. , June 2006. FDA. "FDA approves new psoriasis drug Taltz." “FDA approves Amjevita, a biosimilar to Humira. Medscape: "FDA OKs Biologic Guselkumab (Tremfya) for Plaque Psoriasis." National Psoriasis Foundation.




Health and Quality of Life Outcomes

Reviewed by Debra Jaliman on June 25, 2019

SOURCES:

American Academy of Dermatology. Bhosle, M. , June 2006. FDA. "FDA approves new psoriasis drug Taltz." “FDA approves Amjevita, a biosimilar to Humira. Medscape: "FDA OKs Biologic Guselkumab (Tremfya) for Plaque Psoriasis." National Psoriasis Foundation.




Health and Quality of Life Outcomes

Reviewed by Debra Jaliman on June 25, 2019

NEXT QUESTION:

How do biologic treatments for moderate to severe psoriasis work?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: